Obagi Files 8k Officially Removing Poison Pill, Clears Way For Acquisition - Stock Market News & Financial Analysis -BoardProspects

Obagi Files 8k Officially Removing Poison Pill, Clears Way For Acquisition

Stock Market News & Financial Analysis Jul 11 2012 BoardNews

On February 10, 2012, Voce sent a letter to the Obagi Board of Directors criticizing the Board's adoption of a poison pill and demanding immediate action to address the company's corporate governance failures. Voce's letter in part stated that it believed ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Sorrento Board Rejects Latest Acquisition Proposal also categorized in BoardNews
- Bristol's Merger With Celgene Is Already Paying Dividends: CEO also categorized in BoardNews
- Shareholder Activist Readies Hostile Takeover of Toshiba Unit also categorized in BoardNews
- JP Morgan chief Jamie Dimon Becomes Best-Paid Bank Boss For Fifth Year also categorized in BoardNews
- BlackRock Built 5% Stake in Ex-Toshiba Unit at Centre of Takeover Battle-Filing also categorized in BoardNews
- Ultrapetrol: A Case Study On Questionable Corporate Governance also published in Stock Market News & Financial Analysis
- Regulator Probes Board Role in Credit Suisse Spying Scandal also categorized in BoardNews
- Hedge Fund Makes Huge Bet on Korean Governance Change also categorized in BoardNews
- Japan Activist Investor Yoshiaki Murakami Makes Surprise Bid to Disrupt Toshiba Deal also categorized in BoardNews
- Australia's Westpac Hires Former Barclays Chairman to Tide Over Crisis also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Topics Mentioned
- Board of Directors